ATE376836T1 - Mucinpeptid mit immunstärkenden eigenschaften - Google Patents

Mucinpeptid mit immunstärkenden eigenschaften

Info

Publication number
ATE376836T1
ATE376836T1 AT02757916T AT02757916T ATE376836T1 AT E376836 T1 ATE376836 T1 AT E376836T1 AT 02757916 T AT02757916 T AT 02757916T AT 02757916 T AT02757916 T AT 02757916T AT E376836 T1 ATE376836 T1 AT E376836T1
Authority
AT
Austria
Prior art keywords
peptide
immune
administered
mucin peptide
boosting properties
Prior art date
Application number
AT02757916T
Other languages
English (en)
Inventor
Diana Lopez
Lynn Herbert
Mantley Dorsey
Gunter Kraus
James Hnatyszyn
Original Assignee
Univ Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Miami filed Critical Univ Miami
Application granted granted Critical
Publication of ATE376836T1 publication Critical patent/ATE376836T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001169—Tumor associated carbohydrates
    • A61K39/00117—Mucins, e.g. MUC-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT02757916T 2001-04-02 2002-04-02 Mucinpeptid mit immunstärkenden eigenschaften ATE376836T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28013701P 2001-04-02 2001-04-02

Publications (1)

Publication Number Publication Date
ATE376836T1 true ATE376836T1 (de) 2007-11-15

Family

ID=23071833

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02757916T ATE376836T1 (de) 2001-04-02 2002-04-02 Mucinpeptid mit immunstärkenden eigenschaften

Country Status (11)

Country Link
US (2) US7285282B2 (de)
EP (1) EP1372691B1 (de)
JP (2) JP4223813B2 (de)
KR (1) KR20030092044A (de)
CN (1) CN1525864A (de)
AT (1) ATE376836T1 (de)
BR (1) BR0208771A (de)
CA (1) CA2443045A1 (de)
DE (1) DE60223232T2 (de)
NZ (1) NZ528234A (de)
WO (1) WO2002078607A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1301267C (zh) * 2005-06-21 2007-02-21 中国人民解放军军事医学科学院附属医院 Muc1粘蛋白的一个模拟表位肽及其编码dna与应用
WO2008093166A2 (en) * 2006-05-11 2008-08-07 Ghent University Sialoadhesin-related compositions and methods
CN112574283B (zh) * 2020-12-07 2022-07-05 湖北文理学院 一种人muc1特异性结合多肽及其提取方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2668064B1 (fr) 1990-10-23 1994-12-16 Transgene Sa Composition pharmaceutique pour le traitement ou la prevention d'une tumeur maligne.

Also Published As

Publication number Publication date
NZ528234A (en) 2006-01-27
WO2002078607A3 (en) 2003-03-27
JP2005247861A (ja) 2005-09-15
CA2443045A1 (en) 2002-10-10
BR0208771A (pt) 2004-07-06
WO2002078607A2 (en) 2002-10-10
EP1372691A4 (de) 2005-11-09
US20050095675A1 (en) 2005-05-05
US7285282B2 (en) 2007-10-23
DE60223232D1 (de) 2007-12-13
EP1372691A2 (de) 2004-01-02
US20030166853A1 (en) 2003-09-04
KR20030092044A (ko) 2003-12-03
EP1372691B1 (de) 2007-10-31
CN1525864A (zh) 2004-09-01
JP4223813B2 (ja) 2009-02-12
JP2004532018A (ja) 2004-10-21
DE60223232T2 (de) 2008-08-14

Similar Documents

Publication Publication Date Title
GEP20022695B (en) Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence and Uses Thereof
HUP0303534A2 (hu) Csökkent immunogenitású módosított interferon-béta
SG160205A1 (en) Modified polypeptide
WO2002032923A3 (en) Improved formulations using heat shock/stress protein-peptide complexes
DE69828801D1 (de) Peptide abgeleitet vom bindungs (g) protein des respiratorisches synzytialvirus
WO2004035602A3 (en) Using heat shock proteins and alpha-2-macroglobulins to increase immune response to vaccines
CA2337754A1 (en) Recombinant multivalent malarial vaccine against plasmodium falciparum
DE60143818D1 (de) Alpha-fetoprotein-peptide und ihre verwendung
WO2002034287A3 (en) Therapeutic vaccine formulations containing chitosan
WO2002062843A3 (en) Modified erythropoietin (epo) with reduced immunogenicity
HUP0303309A2 (hu) Csökkentett immunogenitású módosított interferon-alfa
ATE376836T1 (de) Mucinpeptid mit immunstärkenden eigenschaften
DE60313437D1 (de) Mhc klasse i peptidepitope des humanen tumorassoziierten antigens 5t4
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
ATE339446T1 (de) Modifizierter humaner granulozyten makrophagen kolonien stimulierender faktor (gm-csf) mit reduzierter immunogenität
NZ518772A (en) Polypeptide fragments comprising c-terminal portion of helicobacter catalase
JP2004513615A5 (de)
UA83989C2 (ru) Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение
EP1090995A3 (de) Mycoplasma hyopneumoniae Antigen MHP3, dafür kodierendes Gen und Ihre Verwendungen
WO1998022580A3 (en) Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
ATE312923T1 (de) Moraxella catarrhalis basb034 polypeptide und verwendungen davon
HK1092162A1 (en) Biologically active peptides comprising isoleucyl-valyl-threonyl- asparaginyl-threonyl-threonine (ivtntt)
WO2002077034A3 (en) Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity
HUP0402160A2 (hu) T-sejt-epitópok a karboxipeptidáz-G2-ben
WO2001098355A3 (en) Cgi-69 compositions and methods of use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties